
Shares of Vivimed Labs extended gains for the second straight day on Wednesday to jump nearly 12 per cent after Ashish Kacholia, the ace yet not-so-famous investor of Dalal Street bought 4.5 per cent stake in the company, reported CNBC-TV 18.
On Tuesday, Kacholia bought 13,73,713 shares of Vivimed Labs at Rs 90.50 on the NSE. Reacting to the news, the stock hit its fresh 52-week to surge 20 per cent in the previous session, On Wednesday, the stock gained as much as 11.84 per cent on the BSE.
Ashish Kacholia, an influential independent investor, is the founder of Lucky Investment Managers, an investment advisory firm. He started his career with Prime Securities and Edelweiss Equity Research.